Literature DB >> 30444176

Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.

Alexander Baumann1, Adelheid Nebel1, Oliver Granert1, Kathrin Giehl2, Stephan Wolff1, Wiebke Schmidt1, Christin Baasch1, Gerhard Schmidt1, Karsten Witt3, Günther Deuschl1, Gesa Hartwigsen4, Kirsten E Zeuner1, Thilo van Eimeren2,5,6.   

Abstract

BACKGROUND: Hypokinetic dysarthria is highly prevalent in idiopathic Parkinson disease (PD), and effectiveness of high-intensity voice treatment is well established. However, the neural correlates remain largely unknown.
OBJECTIVE: We aimed to specify cerebral pathophysiology of hypokinetic dysarthria and treatment-induced changes using functional magnetic resonance imaging (fMRI).
METHODS: We used fMRI to investigate healthy controls (HCs) and patients with idiopathic PD-associated dysarthria before and after treatment according to the Lee Silverman Voice Treatment LOUD (LSVT). During fMRI, participants covertly read sentences with normal (eg, conversation in a quiet room) or high (eg, shouting on a windy beach) intensity. In addition, we tested LSVT effects on intelligibility and different speech features (intensity, pitch, articulation).
RESULTS: LSVT effectively improved intelligibility, articulation, and pitch in patients. Covert high-intensity speech compared with covert normal-intensity speech led to increased activation of mainly secondary motor areas and bilateral superior and medial temporal regions. Prior to LSVT, patients showed less activity in several speech-associated areas compared with HCs. As a neural correlate of effective LSVT, increased right-sided superior temporal activity correlated with improved intelligibility.
CONCLUSION: This is the first brain imaging study using a covert speech paradigm in PD, which revealed cortical hypoactivation as correlate of hypokinetic dysarthria. Furthermore, cortical correlates of effective LSVT treatment colocalized with the neuronal network, showing increased activation during high- versus normal-intensity speech generation.

Entities:  

Keywords:  Lee Silverman Voice Treatment; functional magnetic resonance imaging; hypokinetic dysarthria; idiopathic Parkinson’s disease; speech therapy

Mesh:

Year:  2018        PMID: 30444176     DOI: 10.1177/1545968318812726

Source DB:  PubMed          Journal:  Neurorehabil Neural Repair        ISSN: 1545-9683            Impact factor:   3.919


  8 in total

1.  The Effect of SPEAK OUT! and The LOUD Crowd on Dysarthria Due to Parkinson's Disease.

Authors:  Alison Behrman; Jennifer Cody; Samantha Elandary; Peter Flom; Shilpa Chitnis
Journal:  Am J Speech Lang Pathol       Date:  2020-05-18       Impact factor: 2.408

2.  The effects of a simulated fMRI environment on voice intensity in individuals with Parkinson's disease hypophonia and older healthy adults.

Authors:  Jordan L Manes; Ellen Herschel; Katharine Aveni; Kris Tjaden; Todd Parrish; Tanya Simuni; Daniel M Corcos; Angela C Roberts
Journal:  J Commun Disord       Date:  2021-08-31       Impact factor: 2.288

3.  The Acoustic Voice Quality Index (AVQI) in People with Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.

Authors:  Gemma Moya-Galé; Jennifer Spielman; Lorraine A Ramig; Luca Campanelli; Youri Maryn
Journal:  J Voice       Date:  2022-04-18       Impact factor: 2.300

4.  Characterization of Mild and Moderate Dysarthria in Parkinson's Disease: Behavioral Measures and Neural Correlates.

Authors:  Hanna Steurer; Ellika Schalling; Erika Franzén; Franziska Albrecht
Journal:  Front Aging Neurosci       Date:  2022-05-16       Impact factor: 5.702

5.  The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial.

Authors:  Erika S Levy; Gemma Moya-Galé; Young Hwa M Chang; Katherine Freeman; Karen Forrest; Mitchell F Brin; Lorraine A Ramig
Journal:  EClinicalMedicine       Date:  2020-06-28

6.  Neurobehavioral Effects of LSVT® LOUD on Auditory-Vocal Integration in Parkinson's Disease: A Preliminary Study.

Authors:  Yongxue Li; Mingdan Tan; Hao Fan; Emily Q Wang; Ling Chen; Jingting Li; Xi Chen; Hanjun Liu
Journal:  Front Neurosci       Date:  2021-02-26       Impact factor: 4.677

7.  Immediate and long-term effects of speech treatment targets and intensive dosage on Parkinson's disease dysphonia and the speech motor network: Randomized controlled trial.

Authors:  Shalini Narayana; Crystal Franklin; Elizabeth Peterson; Eric J Hunter; Donald A Robin; Angela Halpern; Jennifer Spielman; Peter T Fox; Lorraine O Ramig
Journal:  Hum Brain Mapp       Date:  2022-02-10       Impact factor: 5.038

8.  Neuroanatomical regions associated with non-progressive dysarthria post-stroke: a systematic review.

Authors:  Marwa Summaka; Salem Hannoun; Hayat Harati; Rama Daoud; Hiba Zein; Elias Estephan; Ibrahim Naim; Zeina Nasser
Journal:  BMC Neurol       Date:  2022-09-16       Impact factor: 2.903

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.